Foamix Pharmaceuticals Ltd. – Trademark Portfolio
Entity Type: 03
Foamix Pharmaceuticals Ltd. holds 23 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 22 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 10 trademarks are registered. Notable registered marks include ZILXI, AMZEEQ, and VYNE THERAPEUTICS. The owner is based in Ness Ziona.
Holtzman Street 2
POB 4038
Ness Ziona 7414001 , IL
Showing of trademarks Trademarks
Trademark Classifications
Foamix Pharmaceuticals Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does Foamix Pharmaceuticals Ltd. have?
Foamix Pharmaceuticals Ltd. has 23 U.S. trademarks filed with the USPTO. Of these, 10 registered, 12 abandoned, 1 cancelled.
What trademark classes does Foamix Pharmaceuticals Ltd. file in?
Foamix Pharmaceuticals Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Foamix Pharmaceuticals Ltd.'s most well-known trademarks?
Foamix Pharmaceuticals Ltd.'s registered trademark portfolio includes well-known marks such as ZILXI, AMZEEQ, and VYNE THERAPEUTICS. These are among 10 currently registered trademarks in the portfolio.
What is Foamix Pharmaceuticals Ltd.'s trademark registration success rate?
Foamix Pharmaceuticals Ltd. has a 43% trademark registration rate, with 10 out of 23 resolved applications resulting in successful registration. Currently, 0 applications are pending review.